IMMUNITYBIO, INC. Litigation Settlement, Amount Awarded to Other Party
IMMUNITYBIO, INC. (IBRX) reported Litigation Settlement, Amount Awarded to Other Party of $12.00 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LitigationSettlementAmountAwardedToOtherParty · last filed 2021-04-22
- IMMUNITYBIO, INC. litigation settlement, amount awarded to other party for the quarter ending 2020-06-30 was $0.00.
- IMMUNITYBIO, INC. litigation settlement, amount awarded to other party for the quarter ending 2020-03-31 was $12.00M, a 0.00% change year-over-year.
- IMMUNITYBIO, INC. litigation settlement, amount awarded to other party for the quarter ending 2019-12-31 was $0.00.
- IMMUNITYBIO, INC. litigation settlement, amount awarded to other party for the quarter ending 2019-09-30 was $0.00.
| Period end | Litigation Settlement, Amount Awarded to Other Party 1 month | Litigation Settlement, Amount Awarded to Other Party 3 month | Litigation Settlement, Amount Awarded to Other Party 6 month | Litigation Settlement, Amount Awarded to Other Party 9 month | Litigation Settlement, Amount Awarded to Other Party 12 month |
|---|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $12.00M 10-Q · filed 2020-08-07 | $12.00M derived: sum of 3 quarters · filed 2021-04-22 | $12.00M derived: sum of 4 quarters · filed 2021-04-22 | |
| 2020-03-31 | $12.00M 10-Q · filed 2020-05-11 | $12.00M derived: sum of 2 quarters · filed 2021-04-22 | $12.00M derived: sum of 3 quarters · filed 2021-04-22 | $12.00M derived: sum of 4 quarters · filed 2021-04-22 | |
| 2019-12-31 | $0.00 derived: 8-K/A 12 month − 10-Q 9 month · filed 2021-04-22 | $0.00 derived: sum of 2 quarters · filed 2021-04-22 | $0.00 derived: sum of 3 quarters · filed 2021-04-22 | $12.00M 8-K/A · filed 2021-04-22 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $12.00M 10-Q · filed 2019-11-05 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $12.00M 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $12.00M 10-Q · filed 2019-05-08 | ||||
| 2019-01-31 | $12.00M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |